Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

than historical facts) as defined in the Private Securities Litigation Reform Act of 1995 and in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward looking statements. Examples of such risks and uncertainties include, but are not limited to, RXi's need to raise significant capital to fund operations and development of its potential products, the need to establish management and other infrastructure for the RXi subsidiary, intense competition with other companies focused on RNAi and other larger companies with RNAi programs and with other existing or new therapeutic modalities, the early stage of development of RXi's technology, and the scope, timing and outcome of pre-clinical and clinical testing and regulatory review of RXi's potential products. Additional risks or uncertainties are described in CytRx's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

Contact

CytRx Corporation
CEOcast, Inc.
Dan Schustack, 212-732-4300
dschustack@ceocast.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... 19 CareFusion (NYSE: CFN ), a leading, global ... 3,900 CareFusion LTV® 1200 ventilators ordered by the Centers for ... strategic national stockpile. , The CDC ordered a total of ... is the nation,s reserve of medical products used in the ...
... Annual Convention -- Mirixa Corporation, ... announced the launch of MirixaEdge(SM). Previewed to independent pharmacists ... enables pharmacists to design their own patient care programs ... employer, or age. , MirixaEdge capitalizes on the nation,s ...
Cached Medicine Technology:CareFusion Shipping Ventilators to CDC for National Emergency Preparedness 2Mirixa Corporation Announces MirixaEdge(SM) 2
(Date:7/13/2014)... (PRWEB) July 13, 2014 Athletes with ... recovery period from concussions, according to research presented today ... AOSSM ) Annual Meeting. The research marks the first ... based on the known physical events that occur after ... with a long allele in the (GT)n genotype were ...
(Date:7/13/2014)... July 13, 2014 Fadhits.com is popular ... prom dresses are extremely beautiful. Recently, the company has ... for 2014. What’s more, all these outfits are ... off). , Additionally, the supplier is now offering ... elegant Quinceanera dresses, it has many other designs for ...
(Date:7/13/2014)... Wright & Schulte LLC has learned ... in July of 2015, in U.S. District Court, District ... the discovery process in the South Carolina federal ... over the multidistrict litigation (MDL). The complaints pending in ... who allege that they took the statin medication to ...
(Date:7/13/2014)... MI (PRWEB) July 13, 2014 If Dr. ... program he has just launched at http://www.HealthYourself101.com will ... visceral obesity. , Power has set out to provide ... ill effects that’s actually – dare we say it? – ... program,” says Power, “aims to engage the remote learner – ...
(Date:7/12/2014)... a well-known wedding dress manufacturer and retailer, has added a ... its product line. In addition, the company has launched a ... more benefits for its loyal fans. All its brand ... 72% off. , As a leader in the garment industry, ... a good place for ladies who want to purchase charming ...
Breaking Medicine News(10 mins):Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2
... A genomic study of chronic blood cancer - a precursor ... diagnosis using only a blood test, avoiding the need for ... the Wellcome Trust Sanger Institute identified the SF3B1 gene as ... forms of blood cancer. Myelodysplasia is particularly prevalent among people ...
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 26 ... Dinora Rodriguez. "It was a nightmare." Rodriguez had woken ... not move her arms or even close her eyes. And ... case involving breast implants and a facial scar, gone terribly ...
... Maureen Salamon HealthDay Reporter , MONDAY, Sept. 26 ... half of U.S. primary care physicians believe their own patients ... randomly selected from the American Medical Association Physician Masterfile showed ... too much medical care, while 52 percent think the amount ...
... A large-scale data review by researchers in China of ... the endoscopic procedure to be safe and effective for ... a pooled detection rate of 68.1 percent for all ... be the most common indication, with a relatively high ...
... HealthDay Reporter , MONDAY, Sept. 26 (HealthDay News) ... and radiation, can seriously disrupt a couple,s sex life. ... and women figure out what sorts of treatments for erectile ... during sex. In doing so, they returned some luster to ...
... DiabetesIQ, released this week, challenges people to test their ... as they learn about the complexities of the disease, ... million Californians. Developed as a free download by ... Center and QuantiaMD, a company headquartered in Waltham, Massachusetts, ...
Cached Medicine News:Health News:Researchers uncover gene associated with blood cancers 2Health News:Researchers uncover gene associated with blood cancers 3Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 2Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 3Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 4Health News:Many Doctors Think Patients Get Over-Treated, Study Says 2Health News:Many Doctors Think Patients Get Over-Treated, Study Says 3Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 2Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 3Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 4Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 2Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 3Health News:Couples Counseling Boosts Sex Lives After Prostate Cancer 4Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 3
... simplified focusing guidance system has ... to use of its type. Technicians ... LM-770 with a minimum of instruction. ... target lines to focus first. A ...
... is the newest generation of electronic refractors. The ... control the refractor from a keypad that is small ... controls the CP-670 Automatic Chart Projector. The TRS is ... all the lenses are moved for you, taking you ...
The Electric H-Base Table is for heavier instruments, or for those who prefer electric elevation. The electric table easily accepts a slit lamp, a single tabletop, or a double tabletop, just as the M...
The Manual Table Base is elevated with an easy to reach elevating wheel for smooth operation. The table base will accept a slit lamp, a single table top, or a double tabletop for more than one instru...
Medicine Products: